232 related articles for article (PubMed ID: 19767769)
1. Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells.
Shimabe M; Goyama S; Watanabe-Okochi N; Yoshimi A; Ichikawa M; Imai Y; Kurokawa M
Oncogene; 2009 Dec; 28(49):4364-74. PubMed ID: 19767769
[TBL] [Abstract][Full Text] [Related]
2. AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1.
Takeshita M; Ichikawa M; Nitta E; Goyama S; Asai T; Ogawa S; Chiba S; Kurokawa M
Leukemia; 2008 Jun; 22(6):1241-9. PubMed ID: 18337762
[TBL] [Abstract][Full Text] [Related]
3. EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization.
Goyama S; Nitta E; Yoshino T; Kako S; Watanabe-Okochi N; Shimabe M; Imai Y; Takahashi K; Kurokawa M
Leukemia; 2010 Jan; 24(1):81-8. PubMed ID: 19776757
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
Mitani K
Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
[TBL] [Abstract][Full Text] [Related]
5. Evi-1 as a critical regulator of leukemic cells.
Goyama S; Kurokawa M
Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840
[TBL] [Abstract][Full Text] [Related]
6. Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells.
Arai S; Yoshimi A; Shimabe M; Ichikawa M; Nakagawa M; Imai Y; Goyama S; Kurokawa M
Blood; 2011 Jun; 117(23):6304-14. PubMed ID: 21190993
[TBL] [Abstract][Full Text] [Related]
7. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells.
Goyama S; Yamamoto G; Shimabe M; Sato T; Ichikawa M; Ogawa S; Chiba S; Kurokawa M
Cell Stem Cell; 2008 Aug; 3(2):207-20. PubMed ID: 18682242
[TBL] [Abstract][Full Text] [Related]
8. Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.
Tanaka T; Mitani K; Kurokawa M; Ogawa S; Tanaka K; Nishida J; Yazaki Y; Shibata Y; Hirai H
Mol Cell Biol; 1995 May; 15(5):2383-92. PubMed ID: 7739522
[TBL] [Abstract][Full Text] [Related]
9. Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1.
Fukuda S; Hoggatt J; Singh P; Abe M; Speth JM; Hu P; Conway EM; Nucifora G; Yamaguchi S; Pelus LM
Leukemia; 2015 Feb; 29(2):433-40. PubMed ID: 24903482
[TBL] [Abstract][Full Text] [Related]
10. An inhibitory switch derepressed by pbx, hox, and Meis/Prep1 partners regulates DNA-binding by pbx1 and E2a-pbx1 and is dispensable for myeloid immortalization by E2a-pbx1.
Calvo KR; Knoepfler P; McGrath S; Kamps MP
Oncogene; 1999 Dec; 18(56):8033-43. PubMed ID: 10637514
[TBL] [Abstract][Full Text] [Related]
11. Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP.
Nitta E; Izutsu K; Yamaguchi Y; Imai Y; Ogawa S; Chiba S; Kurokawa M; Hirai H
Oncogene; 2005 Sep; 24(40):6165-73. PubMed ID: 15897867
[TBL] [Abstract][Full Text] [Related]
12. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
Sykes DB; Kamps MP
Mol Cell Biol; 2004 Feb; 24(3):1256-69. PubMed ID: 14729970
[TBL] [Abstract][Full Text] [Related]
13. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
14. [Leukemogenesis by the AML1/EVI-1 chimeric protein].
Mitani K; Hirai H
Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):33-9. PubMed ID: 10643333
[No Abstract] [Full Text] [Related]
15. The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cells.
Maicas M; Vázquez I; Alis R; Marcotegui N; Urquiza L; Cortés-Lavaud X; Cristóbal I; García-Sánchez MA; Odero MD
Biochim Biophys Acta Gene Regul Mech; 2017 Jun; 1860(6):721-729. PubMed ID: 28391050
[TBL] [Abstract][Full Text] [Related]
16. Identification of cooperative genes for E2A-PBX1 to develop acute lymphoblastic leukemia.
Sera Y; Yamasaki N; Oda H; Nagamachi A; Wolff L; Inukai T; Inaba T; Honda H
Cancer Sci; 2016 Jul; 107(7):890-8. PubMed ID: 27088431
[TBL] [Abstract][Full Text] [Related]
17. The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBP.
Izutsu K; Kurokawa M; Imai Y; Ichikawa M; Asai T; Maki K; Mitani K; Hirai H
Oncogene; 2002 Apr; 21(17):2695-703. PubMed ID: 11965542
[TBL] [Abstract][Full Text] [Related]
18. Expression and regulation of the evi-1 gene in the human factor-dependent leukemia cell line, UCSD/AML1.
Oval J; Smedsrud M; Taetle R
Leukemia; 1992 May; 6(5):446-51. PubMed ID: 1593910
[TBL] [Abstract][Full Text] [Related]
19. The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence.
Kurokawa M; Ogawa S; Tanaka T; Mitani K; Yazaki Y; Witte ON; Hirai H
Oncogene; 1995 Sep; 11(5):833-40. PubMed ID: 7675444
[TBL] [Abstract][Full Text] [Related]
20. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
